… between the two groups can only be attributed to the potential of SPf66 to modify the risk of
malaria. The results of our trial confirm that the chemically synthesised SPf66 vaccine is safe, …

… vaccines (Graves 2006b). This review considers trials of SPf66 vaccine, while other types of
malaria vaccine are … vaccines will also be prepared when they have reached the trial stage. …

… malaria … SPf66 against clinical P falciparum malaria in Gambian infants. 630 children, aged
6-11 months at time of the first dose, received three doses of SPf66 or injected polio vaccine (…

… This initial study of SPf66 malaria vaccine in Asia constitutes an essential link … malaria
endemic area of Thailand. This study further establishes comparability of US-manufactured SPf66 …

… This paper reports the efficacy results of the randomized, placebo-controlled, field trial of
SPf66 malaria vaccine in Costa Marques, Rondonia, Brazil. This region is characterized by the …

… SPf66 is a synthetic malaria peptide vaccine, which has been widely … SPf66/QS-21 vaccines
were evaluated for safety, tolerability and immunogenicity in healthy adults. The vaccines …

… and protectivity of the synthetic malaria vaccine SPf66 directed against the asexual blood …
directed against the SPf66 molecule. Two of the 185 (1.08%) SPf66-vaccinated and nine of …

… A descriptive study was done to evaluate the safety and immunogenicity of the SPf66 malaria
vaccine: 86 localities, distributed in 10 geographic areas from the Tumaco and Francisco …

… malaria vaccine (19-21). In a phase II trial of the five individuals immunized with the Spf66
vaccine … To evaluate the safety, immunogenicity, and efficacy of the SPf 66 malaria vaccine …

… As part of the programme to evaluate SPf66 as a potential tool for malaria control in Africa,
initiated in 1992, we conducted a trial designed to evaluate the efficacy of SPf66 when …